Short Interest in Haleon PLC Sponsored ADR (NYSE:HLN) Increases By 31.6%

Haleon PLC Sponsored ADR (NYSE:HLN) saw a significant increase in short interest in December. As of December 31st, there was short interest totaling 18,869,983 shares, an increase of 31.6% from the December 15th total of 14,336,665 shares. Currently, 0.4% of the shares of the stock are sold short. Based on an average daily volume of 8,781,092 shares, the days-to-cover ratio is currently 2.1 days. Based on an average daily volume of 8,781,092 shares, the days-to-cover ratio is currently 2.1 days. Currently, 0.4% of the shares of the stock are sold short.

Analyst Upgrades and Downgrades

Several brokerages recently issued reports on HLN. Deutsche Bank Aktiengesellschaft downgraded shares of Haleon from a “hold” rating to a “sell” rating in a research report on Monday, January 12th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Haleon in a research note on Wednesday, October 8th. Finally, Morgan Stanley reissued an “overweight” rating on shares of Haleon in a research note on Monday, December 15th. One research analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating, four have given a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, the stock presently has an average rating of “Hold” and a consensus target price of $12.33.

Institutional Investors Weigh In On Haleon

Large investors have recently bought and sold shares of the company. Hanson & Doremus Investment Management raised its holdings in Haleon by 234.1% in the second quarter. Hanson & Doremus Investment Management now owns 2,372 shares of the company’s stock worth $25,000 after purchasing an additional 1,662 shares during the period. Golden State Wealth Management LLC raised its stake in Haleon by 107.6% during the 2nd quarter. Golden State Wealth Management LLC now owns 2,721 shares of the company’s stock worth $28,000 after buying an additional 1,410 shares during the period. SOA Wealth Advisors LLC. lifted its holdings in Haleon by 60.5% during the third quarter. SOA Wealth Advisors LLC. now owns 3,105 shares of the company’s stock worth $28,000 after acquiring an additional 1,170 shares in the last quarter. Citizens National Bank Trust Department grew its stake in Haleon by 167.4% in the third quarter. Citizens National Bank Trust Department now owns 3,276 shares of the company’s stock valued at $29,000 after acquiring an additional 2,051 shares during the period. Finally, Hilltop National Bank acquired a new position in Haleon in the second quarter valued at about $33,000. Institutional investors own 6.67% of the company’s stock.

Haleon Price Performance

Shares of HLN opened at $9.84 on Friday. The stock has a market cap of $43.82 billion, a P/E ratio of 25.23 and a beta of 0.19. Haleon has a 1 year low of $8.71 and a 1 year high of $11.42. The stock’s 50-day moving average price is $9.81 and its two-hundred day moving average price is $9.61. The company has a current ratio of 0.87, a quick ratio of 0.63 and a debt-to-equity ratio of 0.48.

About Haleon

Haleon plc (NYSE:HLN) is a global consumer healthcare company formed through the separation of a large pharmaceutical group’s consumer health business in 2022. Headquartered in the United Kingdom, Haleon develops, manufactures and markets a broad portfolio of over‑the‑counter medicines, oral health products, vitamins, minerals and supplements, and other consumer health goods designed for daily self‑care and symptom relief.

The company’s product mix spans categories such as oral care (toothpastes and sensitivity treatments), pain relief and analgesics, respiratory remedies, digestive health products, topical treatments and nutritional supplements.